GLP-1 Receptor Agonists and Reproductive Health: Implications for Contraception, Fertility, and Pregnancy. (PubMed, Endocrinol Metab Clin North Am) - Oct 23, 2026 - "Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly expanded in use for the treatment of obesity and type 2 diabetes, including among women of reproductive age...Most GLP-1 RAs do not significantly affect oral contraceptive pharmacokinetics, although tirzepatide may require temporary backup contraception. Evidence regarding fertility outcomes and pregnancy safety remains limited."
Journal • Review • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Polyendocrine Metabolic Ovarian Syndrome • Type 2 Diabetes Mellitus
|
|
Fatima Cody Stanford; Florence Porterfield; Jennifer Mulligan; Katherine Salim; Olayemi Olubowale
|